TRANSGLIOMA
New treatments for glioblastoma through a cross-border translational research platform
01/2016 - 1b
Grunnupplýsingar
-
Stutt lýsing á ráðgjafarfyrirtækinuTRANSGLIOMA faces the challenges identified by the EU2020 plan and the Italy-Slovenia Program. It is an implementation of the Interreg GLIOMA project, which discovered new cancer stem cell markers which will be used in a clinical environment for early diagnosis, response to treatment and as a therapeutic target. The innovative approach will allow single patients to receive a personalised treatment, contributing to an improvement in the quality of life of patients with brain tumours.
- Fyrirhuguð upphaf verkefnis 01.09.2017 Áætluð verklok 29.02.2020
- Lengd 29 (Mánuðum))
Fjárhagsáætlun
- Heildarfjárhagsáætlun áætlunarinnar / símtalið 1302252 Verkefni ESB-fjármögnun 1106915 Hlutfall: 85
Samstarfsaðilar
Skjöl
-
eins og er eru engin skjöl tiltæk fyrir þessa skrá